GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
-15.87%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$203M
AUM Growth
+$203M
Cap. Flow
-$126M
Cap. Flow %
-61.88%
Top 10 Hldgs %
54.94%
Holding
59
New
7
Increased
8
Reduced
10
Closed
22

Top Buys

1
VRTX icon
Vertex Pharmaceuticals
VRTX
$13.3M
2
IOVA icon
Iovance Biotherapeutics
IOVA
$8.85M
3
BOLD
Audentes Therapeutics, Inc
BOLD
$6.4M
4
FOLD icon
Amicus Therapeutics
FOLD
$6.23M
5
ANAB icon
AnaptysBio
ANAB
$5.1M

Top Sells

1
PTCT icon
PTC Therapeutics
PTCT
$23.5M
2
ECYT
Endocyte, Inc. Common Stock
ECYT
$19.5M
3
TSRO
TESARO, Inc.
TSRO
$17.6M
4
SRPT icon
Sarepta Therapeutics
SRPT
$15.3M
5
ASMB icon
Assembly Biosciences
ASMB
$12.1M

Sector Composition

1 Healthcare 82.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALNY icon
26
Alnylam Pharmaceuticals
ALNY
$58.6B
$2.55M 0.93%
35,000
-140,000
-80% -$10.2M
ARVN icon
27
Arvinas
ARVN
$580M
$2.25M 0.82%
175,000
– –
ACAD icon
28
Acadia Pharmaceuticals
ACAD
$4.34B
$2.02M 0.73%
125,000
-375,000
-75% -$6.06M
UROV
29
DELISTED
Urovant Sciences Ltd.
UROV
$1.98M 0.72%
300,000
– –
GYRE icon
30
Gyre Therapeutics
GYRE
$734M
$1.58M 0.57%
200,000
– –
GNCA
31
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.01M 0.37%
3,525,000
– –
KA
32
DELISTED
Kineta, Inc. Common Stock
KA
$616K 0.22%
+190,000
New +$616K
SAGE
33
DELISTED
Sage Therapeutics
SAGE
$316K 0.11%
3,300
-6,200
-65% -$594K
MOTS
34
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$311K 0.11%
100,000
– –
MDGL icon
35
Madrigal Pharmaceuticals
MDGL
$9.7B
$101K 0.04%
900
-13,300
-94% -$1.49M
ECYT
36
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-1,100,000
Closed -$19.5M
TSRO
37
DELISTED
TESARO, Inc.
TSRO
– –
-450,000
Closed -$17.6M
RDUS
38
DELISTED
Radius Health, Inc.
RDUS
– –
-200,000
Closed -$3.56M
SPPI
39
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-47,200
Closed -$793K
GRTS
40
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
-75,000
Closed -$1.07M
ITCI
41
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
0
– –
XBI icon
42
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
TGTX icon
43
TG Therapeutics
TGTX
$5.03B
– –
-45,500
Closed -$255K
PTCT icon
44
PTC Therapeutics
PTCT
$4.41B
– –
-500,000
Closed -$23.5M
PDSB icon
45
PDS Biotechnology
PDSB
$60.6M
– –
-1,000,000
Closed -$820K
NGNE icon
46
Neurogene
NGNE
$284M
– –
-500,000
Closed -$1.47M
KURA icon
47
Kura Oncology
KURA
$732M
– –
-230,000
Closed -$4.03M
INSM icon
48
Insmed
INSM
$30.3B
– –
-26,000
Closed -$526K
CBIO
49
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
– –
-400,000
Closed -$5.76M
FATE icon
50
Fate Therapeutics
FATE
$115M
– –
-75,000
Closed -$1.22M
1
2
3